Blood test monitoring for glioblastoma treated with chemoradiation and oxygen therapy
Part of Cancer clinical trials.
This substudy looks at a blood test (liquid biopsy) to track glioblastoma during standard chemoradiation and an experimental oxygen-boosting drug. It aims to see if the test can help monitor the tumor more easily than scans alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must already be part of the RESTORE study (a main trial for glioblastoma treatment).
- You need to have signed the consent form for this separate substudy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a higher dose of radiation to the tumor area improves outcomes for people with glioblastoma. It is for those who have had surgery or are planned for radiation, and have some remaining tumor.
This trial tests whether customized drug screening on your tumor cells can help doctors choose the best treatment for you. Your tumor cells will be grown in the lab and tested against different drugs to find what works best, combined with short-course radiation therapy.
This trial is testing whether a drug called G-CSF (which helps boost white blood cells) can help people with glioblastoma who are already receiving standard treatment with radiation and chemotherapy (temozolomide). It aims to see if G-CSF can reduce side effects and improve outcomes.
This study tests whether using a continuous glucose monitor (a small device that tracks blood sugar levels) can help manage high blood sugar in people newly diagnosed with glioblastoma, a type of brain cancer. It aims to see if this monitoring can improve overall health during treatment.
This study uses special MRI scans to measure oxygen levels in and around glioblastoma before and during radiation treatment. It may help researchers understand how oxygen affects treatment response and timing.
This trial tests whether testing drugs on your tumor cells in a lab can help find the best treatment for you. It is for people with a specific type of glioblastoma that has not been treated yet.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.